List of Studies ( Metabolite:Asn-Asp)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002505 | AN004126 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | Peak area |
ST002787 | AN004535 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | Peak area |
ST002926 | AN004798 | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Blood | Plasmodium falciparum | Malaria | Monash University | peak height |
ST003144 | AN005159 | On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity | Blood | Plasmodium falciparum | Malaria | Monash University | peak height |
ST000403 | AN000642 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000539 | AN000818 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000546 | AN000832 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height |
ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | Peak height | |
ST003179 | AN005222 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST003565 | AN005858 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST002407 | AN003924 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract | Intestine | Human | UC Davis | Peak Height | |
ST001794 | AN002912 | Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples | Intestine | Human | University of California, Davis | Peak Height Intensity | |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002106 | AN003445 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST002107 | AN003446 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST002108 | AN003448 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST002512 | AN004137 | Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta | Intestine | Mouse | University of California, San Francisco | relative ion counts | |
ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | Signal Intensity |
ST001304 | AN002172 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | Signal Intensity |